-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
1,872,142 shares
-
Security Ownership %
-
4.9%
Novo Holdings A/S ownership in ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share
14 Aug 2025 - Novo Holdings A/S has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,872,142 shares of ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share.
This represents 4.9% ownership of the company.
In their previous filing dated 14 Feb 2025, Novo Holdings A/S had reported owning 1,750,000 shares, indicating an increase of +7%.
.